Literature DB >> 24783034

Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy.

Wilmar M Wiersinga1, Noortje I Regensburg2, Maarten P Mourits2.   

Abstract

Graves' ophthalmopathy (GO) is characterized by swelling of orbital fat and extraocular muscles, but little attention has been given to differential involvement of fat and muscles. Advancements in imaging allow rather accurate measurements of orbital bony cavity volume (OV), fat volume (FV) and muscle volume (MV), and are the topics of this review. Ratios of FV/OV and MV/OV neutralize gender differences. In adult Caucasian controls, mean values ± SD of FV/OV are 0.56 ± 0.11 and of MV/OV are 0.15 ± 0.02. FV increases substantially and MV decreases slightly with advancing age, requiring age-specific reference ranges. In 95 consecutive untreated Caucasian GO patients, both FV and MV were within normal limits in 25%, increased FV but normal MV was present in 5%, normal FV but increased MV was detected in 61%, and both increased FV and MV was evident in 9%. Increased FV was associated with more proptosis and longer GO duration. Increased MV was associated with older age, more severe GO (more proptosis and diplopia, worse eye muscle ductions), higher TBII and current smoking. At the cellular and molecular level differential involvement of fat and muscles might be related to differences between fibroblast phenotypes and cytokine profiles in each compartment, to different orbital T cell subsets during the course of the disease and to peroxisome proliferator activator receptor-γ polymorphisms and modulation of 11β-hydroxysteroid dehydrogenase-1. Enlarged muscles are apparently a rather early phenomenon in GO, whereas increases in fat mass occur relatively late. Why a minor subset of GO patients presents with an increase of only fat remains poorly understood.

Entities:  

Keywords:  Determinants; Extraocular muscles; Graves’ ophthalmopathy; Orbital fat; Volumetry

Year:  2013        PMID: 24783034      PMCID: PMC3821503          DOI: 10.1159/000348246

Source DB:  PubMed          Journal:  Eur Thyroid J        ISSN: 2235-0640


  44 in total

1.  Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.

Authors:  Zsolt Szucs-Farkas; Judit Toth; Jozsef Kollar; Laszlo Galuska; Kenneth D Burman; Judit Boda; Andras Leovey; Jozsef Varga; Bernadett Ujhelyi; Jeno Szabo; Andras Berta; Endre V Nagy
Journal:  Thyroid       Date:  2005-02       Impact factor: 6.568

2.  The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease.

Authors:  W R Nunery; R T Martin; G W Heinz; T J Gavin
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993-06       Impact factor: 1.746

3.  Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts.

Authors:  Rosanee W Valyasevi; Debra A Harteneck; Charyl M Dutton; Rebecca S Bahn
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

4.  Effect of smoking on orbital fat and muscle volume in Graves' orbitopathy.

Authors:  Noortje I Regensburg; Wilmar M Wiersinga; Tos T J M Berendschot; Peerooz Saeed; Maarten P Mourits
Journal:  Thyroid       Date:  2010-12-12       Impact factor: 6.568

5.  Cytokine profiles in eye muscle tissue and orbital fat tissue from patients with thyroid-associated ophthalmopathy.

Authors:  Y Hiromatsu; D Yang; T Bednarczuk; I Miyake; K Nonaka; Y Inoue
Journal:  J Clin Endocrinol Metab       Date:  2000-03       Impact factor: 5.958

6.  Quantitative morphometry of the orbit in Chinese adults based on a three-dimensional reconstruction method.

Authors:  Yongrong Ji; Zanqun Qian; Yang Dong; Huifang Zhou; Xianqun Fan
Journal:  J Anat       Date:  2010-08-30       Impact factor: 2.610

7.  Magnetic resonance imaging characterization of orbital changes with age and associated contributions to lower eyelid prominence.

Authors:  Sean J Darcy; Timothy A Miller; Robert A Goldberg; J Pablo Villablanca; Joseph L Demer; George H Rudkin
Journal:  Plast Reconstr Surg       Date:  2008-09       Impact factor: 4.730

8.  Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic.

Authors:  P Perros; A L Crombie; J N Matthews; P Kendall-Taylor
Journal:  Clin Endocrinol (Oxf)       Date:  1993-04       Impact factor: 3.478

9.  Volume measurements of normal orbital structures by computed tomographic analysis.

Authors:  G Forbes; D G Gehring; C A Gorman; M D Brennan; I T Jackson
Journal:  AJR Am J Roentgenol       Date:  1985-07       Impact factor: 3.959

10.  Correlation of CT scanning and pathologic features of ophthalmic Graves' disease.

Authors:  S L Trokel; F A Jakobiec
Journal:  Ophthalmology       Date:  1981-06       Impact factor: 12.079

View more
  15 in total

1.  Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy.

Authors:  Tomoaki Higashiyama; Yasuhiro Nishida; Masahito Ohji
Journal:  Jpn J Ophthalmol       Date:  2015-09-01       Impact factor: 2.447

2.  Quantitative analysis of orbital soft tissues on computed tomography to assess the activity of thyroid-associated orbitopathy.

Authors:  Jun Soo Byun; Nam Ju Moon; Jeong Kyu Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-11-12       Impact factor: 3.117

3.  [Calculation of orbital fat volumes for determining treatment timing for thyroid- associated ophthalmopathy].

Authors:  Wei Jiang; Qiu-Yue Cai; Zhang-Fang Li; Zhi-Yi Chen; Yao-Sheng Luo; Shi-di Hu; Jie Shen
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-05-20

4.  Imaging biomarkers in thyroid eye disease and their clinical associations.

Authors:  Shikha Chaganti; Katrina Nelson; Kevin Mundy; Robert Harrigan; Robert Galloway; Louise A Mawn; Bennett Landman
Journal:  J Med Imaging (Bellingham)       Date:  2018-10-16

5.  Geriatric patients are predisposed to strabismus following thyroid-related orbital decompression surgery: A multivariate analysis.

Authors:  Chris Y Wu; Alon Kahana
Journal:  Orbit       Date:  2017-02-14

Review 6.  The risk factors for Graves' ophthalmopathy.

Authors:  Jiamin Cao; Yuhe Su; Zhuokun Chen; Chen Ma; Wei Xiong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-11-17       Impact factor: 3.117

Review 7.  Thinking inside the box: Current insights into targeting orbital tissue remodeling and inflammation in thyroid eye disease.

Authors:  Vardaan Gupta; Christine L Hammond; Elisa Roztocil; Mithra O Gonzalez; Steven E Feldon; Collynn F Woeller
Journal:  Surv Ophthalmol       Date:  2021-09-04       Impact factor: 6.197

8.  Increased Orbital Muscle Fraction Diagnosed by Semi-Automatic Volumetry: A Risk Factor for Severe Visual Impairment with Excellent Response to Surgical Decompression in Graves' Orbitopathy.

Authors:  Christine Steiert; Sebastian Kuechlin; Waseem Masalha; Juergen Beck; Wolf Alexander Lagrèze; Juergen Grauvogel
Journal:  J Pers Med       Date:  2022-06-06

Review 9.  Peroxisome Proliferator-Activated Receptor- γ in Thyroid Autoimmunity.

Authors:  Silvia Martina Ferrari; Poupak Fallahi; Roberto Vita; Alessandro Antonelli; Salvatore Benvenga
Journal:  PPAR Res       Date:  2015-02-01       Impact factor: 4.964

10.  Possible additional MRI markers for critical brain swelling with increased intracranial pressure in children?

Authors:  Thierry Agm Huisman; Misun Hwang; Gunes Orman
Journal:  Neuroradiol J       Date:  2021-05-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.